Patient communication in precision medicine trials is prone to specific failure points: complex scientific content that participants cannot easily interpret, co...
Continue reading
Natural history studies play a pivotal role in understanding how diseases develop and progress over time. These observational studies track disease trajectories...
Continue reading
Last week, we attended the NASH-TAG conference in beautiful Park City, Utah. Against a winter wonderland backdrop, we dove deep into the latest research on meta...
Continue reading
In the ever-changing field of precision medicine, continuous evaluation of data sharing and collaboration practices is essential for biotech and pharma companie...
Continue reading
Drug development remains one of the most complex, costly, and failure-prone processes in the life sciences. Traditional approaches rely heavily on trial-and-err...
Continue reading
As the new year unfolds, it's a time for reflection on some of the most inspirational stories in human genetics last year, and anticipation of what's to come in...
Continue reading
Genetics now shapes how medicines are developed, how patients are diagnosed, and how clinical decisions are made. Yet a persistent gap exists between the pace o...
Continue reading
Genetic variation across populations has direct consequences for precision medicine trial design. As patient populations in clinical research become more ethnic...
Continue reading
Health equity, defined as everyone having the opportunity to be as healthy as possible, has long been a primary goal of public health. Still, across the world, ...
Continue reading
Our new whitepaper "Inclusive genomics: A path to equitable precision medicine" offers a close look at the intersection of genomic research and diversity. It's ...
Continue reading